Association of high-grade serous ovarian cancer sample clonality with clinical outcomes

被引：0
作者：
Ulmer, Keely [1 ]
Stephens, Harvey [1 ]
Gabrilovich, Sofia [1 ]
Polio, Andrew [1 ]
Bender, David [1 ]
Goodheart, Michael [1 ]
Bosquet, Jesus Gonzalez [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1147
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [21] Cell Origins of High-Grade Serous Ovarian Cancer
    Kim, Jaeyeon
    Park, Eun Young
    Kim, Olga
    Schilder, Jeanne M.
    Coffey, Donna M.
    Cho, Chi-Heum
    Bast, Robert C., Jr.
    CANCERS, 2018, 10 (11)
  • [22] High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
    Lisio, Michael-Antony
    Fu, Lili
    Goyeneche, Alicia
    Gao, Zu-hua
    Telleria, Carlos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [23] P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.
    Mandilaras, Victoria
    Garg, Swati
    Burnier, Julia
    Karakasis, Katherine
    Wang, Lisa
    Mackay, Helen
    Dhani, Neesha C.
    Butler, Marcus O.
    Rodriguez-Freixinos, Victor
    Wilson, Michelle K.
    Martin-Lorente, Cristina
    Ethier, Josee-Lyne
    Bedard, Philippe L.
    Siu, Lillian L.
    Clarke, Blaise
    Shaw, Patricia Ann
    Stockley, Tracy
    Oza, Amit M.
    Lheureux, Stephanie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] The genomic profile of high-grade serous ovarian cancer and its association with platinum resistance
    Montemorano, Lauren
    Lang, Jessica
    Shultz, Zoey
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard
    Hartenbach, Ellen
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S290 - S291
  • [25] Evaluating the impact of a history of breast cancer on outcomes in women with high-grade serous ovarian cancer
    Gillen, J.
    Rowland, M.
    Liu, A. Y.
    Vesely, S.
    Powell, B.
    Blank, S. V.
    Krutz, M.
    Frey, M. K.
    Freeman, J.
    Cass, I.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 212 - 212
  • [26] A multi-sample study reveals the evolution and heterogeneity in high-grade serous ovarian cancer
    Wong, Siao-Han
    Doberstein, Kai
    Marme, Frederik
    Brors, Benedikt
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd
    Frederick A. Dick
    Cell Division, 17
  • [28] Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
    Buttarelli, Marianna
    De Donato, Marta
    Raspaglio, Giuseppina
    Babini, Gabriele
    Ciucci, Alessandra
    Martinelli, Enrica
    Baccaro, Pina
    Pasciuto, Tina
    Fagotti, Anna
    Scambia, Giovanni
    Gallo, Daniela
    CANCERS, 2020, 12 (04)
  • [29] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12) : 1169 - 1174
  • [30] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
12345